Prof.
Adrian J. Lowe obtained his doctorate in epidemiology in 2008 from the University of Melbourne. Currently,
he is a Dame Kate Campbell Fellow and Co-Head of the University of Melbourne’s
Allergy and Lung Health Unit. He is the principal investigator (PI) of the
PEBBLES trial, an NHMRC-funded clinical trial using a novel skin barrier
intervention for the prevention of eczema and food allergy in infants.
Furthermore, he is also a co-PI of the Melbourne Atopy Cohort Study (MACS), a
family study of allergic disease, and a co-investigator on HealthNuts, a study
to determine the prevalence and risk factors for food allergy. His research
focuses on the epidemiology of eczema and strategies to prevent its
development and progression into other forms of allergic diseases.
Prof.
Adrian J. Lowe obtained his doctorate in epidemiology in 2008 from the University of Melbourne. Currently,
he is a Dame Kate Campbell Fellow and Co-Head of the University of Melbourne’s
Allergy and Lung Health Unit. He is the principal investigator (PI) of the
PEBBLES trial, an NHMRC-funded clinical trial using a novel skin barrier
intervention for the prevention of eczema and food allergy in infants.
Furthermore, he is also a co-PI of the Melbourne Atopy Cohort Study (MACS), a
family study of allergic disease, and a co-investigator on HealthNuts, a study
to determine the prevalence and risk factors for food allergy. His research
focuses on the epidemiology of eczema and strategies to prevent its
development and progression into other forms of allergic diseases.